Trending
- Scientists discover hidden “master switch” driving skin cancer growth and immune escape
- LITESPARK-012 Trial Does Not Meet Primary End Point for Advanced RCC Group
- Interstitial loss of heterozygosity at Chr19q13 in CD33-negative AML
- Optimizing Targeted Therapy in Early-Stage EGFR-Mutated NSCLC
- Ukraine family get cancer and bomb news on same day
- Work begins on Sir Bobby Robson cancer centre
- MRD End Point Brings “Positive Change” to Multiple Myeloma Research
- Translating Innovation Into Practice: Highlights From the 43rd Annual Miami Breast Cancer Conference
